Showing results (1651-1660 of 1,834) with videos related to
Sort By:
Pageof 184
Journal of Clinical Lipidology|October 22, 2018
Decreased GlycA after lifestyle intervention among obese, prediabetic adolescent LatinosMicah L Olson, Ana Rentería-Mexía, Margery A Connelly, et al.European Review for Medical and Pharmacological Sciences|September 20, 2018
Screening of parathyroid gland by high frequency ultrasound and the relationship between recurrent urinary calculi and primary hyperparathyroidismH-X Dai, J-W Li, Y-Q Zhang, et al.Nature Communications|August 22, 2018
Direct observation of room-temperature out-of-plane ferroelectricity and tunneling electroresistance at the two-dimensional limitH Wang, Z R Liu, H Y Yoong, et al.Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|April 3, 2023
[Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses]D D Tan, Y D Liu, Y B Fan, et al.Leukemia|October 26, 2007
Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samplesL-Y Shih, D-C Liang, C-F Huang, et al.American Journal of Medical Genetics|April 9, 1996
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigreeJ M Silverman, D A Greenberg, L D Altstiel, et al.Cell Reports|April 3, 2020
Targeting the Extrinsic Pathway of Hepatocyte Apoptosis Promotes Clearance of Plasmodium Liver InfectionGregor Ebert, Sash Lopaticki, Matthew T O'Neill, et al.Plos One|January 19, 2012
Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3Hannah P Yang, Rosemary E Zuna, Mark Schiffman, et al.Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|July 27, 2011
CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer riskTracy A O'Mara, Kaltin Ferguson, Paul Fahey, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 studyA R Hansen, C Massard, P A Ott, et al.Pageof 184